The University of Michigan Division of Rheumatology is recognized for excellence in the diagnosis and management of rheumatic and musculoskeletal diseases – our research has an impact on patient care throughout the United States and abroad. We are dedicated to defining the causes, cures, and prevention of rheumatic diseases. This dedication has put us at #12 in the nation according to the 2017-2018 US News & World Report.
Our care team consists of physicians, physician assistants, nurses, and staff who are experts in a vast array of rheumatic diseases such as rheumatoid arthritis, lupus, scleroderma, vasculitis, autoimmune muscle diseases, Sjogren's Syndrome, psoriatic arthritis, ankylosing spondylitis, gout, osteoarthritis, osteoporosis, and many other types of musculoskeletal diseases.
Our clinical and laboratory based researchers work closely together with the common goal of improving the lives of our patients. I am especially proud of this team approach which can be seen in our Lupus Program and Scleroderma Program.
The division's Rheumatology Fellowship Training Program is designed to provide the necessary skills for trainees to focus their talents on investigation and treatment of the rheumatic diseases, and to succeed in careers in academic and clinical medicine. Our program is a two-year program, with the first year geared towards providing inpatient and outpatient experience, while the focus for the second year shifts towards research.
We welcome you to explore and find out more about who we are and what we do in the Division of Rheumatology. Please feel free to contact us with any questions.
David A. Fox, MD
Chief, Division of Rheumatology